News > Moderna’s boosted valuation has Tesla-like spin

Moderna’s boosted valuation has Tesla-like spin

There's the possibility of an mRNA influenza vaccine, which Chief Executive Stéphane Bancel hopes might be combined with the Covid shot. Drugmakers Pfizer and BioNTech said on 5 Jan, that they would develop a vaccine for shingles based on the mRNA technology used in their Covid-19 vaccine. Rival pharmaceutical firm Moderna also produced its Covid-19 vaccine using mRNA technology.